is human glutathione synthetase a tim barrel Team:UNSW Australia/Model/Glutathione System
Description
Ramiro-Gonzalez MD
In T2D patients, the incidence of severe ED increases with age
We will continue to screen the exosomal components, to find the novel factor involved in renal toxicity
The selective ULK1/2 inhibitor, DCC-3116, synergizes with the KRASG12C inhibitor sotorasib to suppress KRAS-driven LC, whereas this combination has been assessed only in early preclinical stages and lacks predictive biomarkers for patient stratification (17)
